OUR STORY

Gemstone Biotherapeutics was founded in Baltimore, MD in 2013 as a pre-clinical research and development initiative built on a foundation of exclusively-licensed IP from The Johns Hopkins University. We are currently focused on incubating and commercializing two specific wound healing products from our pipeline that target and repair the physiological deficiencies of acute and chronic wounds to heal them more rapidly and ensure they remain healed.

 

Our best-in-class research collaborators include clinical and commercial institutions, including NYU Winthrop University Hospital, The Johns Hopkins University, and UPenn School of Veterinary Medicine. We are moving our technology through FDA approval, clinical trials, reimbursement studies in support of future productizing, licensing, or other strategic partnerships.

Our Team

Emily English

Emily English, Ph.D.

Chief Operating Officer

Dr. English leads Gemstone Bio’s product development, helping to bring innovative wound healing technologies from the lab bench into the clinic. She spent eight years as a staff scientist and global communications program manager at the Johns Hopkins University Applied Physics Laboratory and she holds a Bachelor’s degree, Magna cum laude, in chemistry from the University of Maryland, College Park, as well as a Ph.D. in chemistry from the University of Wisconsin, Madison.

Matt Davenport

Matt Davenport

Director of Engineering

Matt graduated from The Johns Hopkins University with a BS/MSE in Chemical and Biomolecular Engineering. At Johns Hopkins, Matt worked in the lab of Dr. Sharon Gerecht and was a key researcher in the development of Gemstone’s core technology. He brings a vast background in material science, bioengineering, and downstream processing to Gemstone. His past research experiences include Myriant Technologies and the European Molecular Biology Laboratories (EMBL).

Janty Shoga

Janty Shoga

Research Engineer

Janty graduated from the Univ. of Delaware with a BS in Mechanical Engineering and an MS in Biomechanics. At the Univ. of Delaware, Janty’s research focused on the solid and fluid mechanics involved in musculoskeletal tissues and how these macroscale mechanics affect microscale cell behavior. Prior to joining Gemstone, Janty was the Lead Product Development Engineer at JADE Biotech, a startup that aimed to create a device to manage and audit medical narcotic waste.

Inventors

Sharon Gerecht, Ph.D.

Johns Hopkins University

Professor of Chemical & Biomolecular Engineering and Materials Science at the Whiting School of Engineering.  Director of the Institute for NanoBio Technology (INBT).

Jeremy Walston, MD

Johns Hopkins Bayview Medical Center

Raymond and Anna Lublin Professor of Geriatric Medicine at JHMI; Co-Director of the Biology of Healthy Aging Program in the Division of Geriatric Medicine and Gerontology.

Peter Abadir, MD

Johns Hopkins Bayview Medical Center

Assistant Professor of Geriatric Medicine and Gerontology at JHMI.

Scientific Advisory Board

Susan Volk, Ph.D., V.M.D.

University of Pennsylvania

Associate Professor of Small Animal Surgery, School of Veterinary Medicine, University of Pennsylvania.

Ronald Sherman, D.P.M., MBA

The Johns Hopkins Hospital

Podiatric Surgeon in the Dept of Surgery: Division of Vascular Surgery at Johns Hopkins Hospital.  Member of the Multidisciplinary Diabetic Foot & Wound Clinic.

Teresa Compton, Ph.D.

Pharmaceutical Industry Consultant

Former VP of Translational Medicine and Virology at Biogen Idec and former Executive Director at Novartis.

Marc Dauer, MD

Dauer Hair Restoration

Medical Director of Dauer Hair Restoration.

David Abramson, MD

Englewood Hospital, Mt. Sinai School of Medicine

Chief of Plastic Surgery at Englewood Hospital.  Associate Clinical Professor of Surgery at Mt. Sinai School of Medicine.

Board of Directors

David Oros

Gamma 3

Founding Partner of Gamma 3 LLC.  Chairman of Gemstone and Terbium Labs.  Former Chairman and CEO of Aether Systems, Inc.

 

Geoff Mackay

AVROBIO

Founder, President and CEO of AVROBIO, Inc. in Cambridge, MA. Former Chairman of the Board of the Alliance for Regenerative Medicine, and former President and CEO of Organogenesis.

Xin Huang, MD, Ph.D.

Cowin Venture Capital

Managing Partner at Cowin Venture and leader of the firm’s healthcare sector.

Our Collaborators

Polysciences Inc
Idfive
Abel Communications
Fast Forward
Katecho
Polymer Solutions
Biologics

Join Our Team

Interested in our work? Then we’re interested in you.